The armamentarium for the medical treatment of glaucoma recently experienced an
unprecedented expansion of available agents. Years ago, the choice was limited to miotics …

• Betaxolol hydrochloride (0.5%) and timolol maleate (0.5%) were compared in a six-month
randomized, double-blind study involving 29 patients with glaucoma. The two drugs were …

In two different medical centers, a total of 24 normal individuals (mean age, 31 years)
participated in a double-masked, three-way crossover single-instillation comparison of …

Chronic open angle glaucoma is asymptomatic and generally detected by optometrists. It is
increasingly common with age affecting about 5% of those over 65 and is responsible for …

Thirty-three eyes of 22 patients with primary open-angle glaucoma or severe ocular
hypertension had topical timolol maleate added to their maximally tolerated medical …

Some beta-adrenoceptor blocking drugs are exciting new ocular hypotensive compounds.
Unlike pilocarpine, the mainstay of glaucoma treatment for the last 100 years, beta-blocking …

Glaucoma is a common eye condition that affects millions of individuals worldwide, making it
the second-leading cause of blindness. Because glaucoma is associated with increased IOP …

[Efficacy and safety of substituting a twice-daily regimen of timolol with a single daily instillation
of nonpreserved beta-blocker in patients with chronic glaucoma or ocular hypertension] …

Topical ophthalmic β‐adrenoceptor antagonists (beta‐blockers) are generally recognized as
the treatment of choice in glaucoma management due to favourable efficacy, safety and …